Pourquoi les nouveaux médicaments sont-ils si chers ?
Med Sci (Paris), 34 4 (2018) 354-361
Published online: 2018-04-16
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Les enjeux éthiques soulevés par les biothérapies
Pierre-Henri Duée, Sophie Crozier, Florence Jusot and Jean-François DelfraissyAnnales des Mines - Réalités industrielles Novembre 2023 (4) 112 (2023)
https://doi.org/10.3917/rindu1.234.0112
The Agro-Economic Feasibility of Growing the Medicinal Plant Euphorbia peplus in a Modified Vertical Hydroponic Shipping Container
Françoise Bafort, Stephan Kohnen, Etienne Maron, et al.Horticulturae 8 (3) 256 (2022)
https://doi.org/10.3390/horticulturae8030256
The CECMED Office of Innovation: A Core Initiative to Bolster Novel Pharmaceutical Products-The Cuban Approach
Belkis Romeu and Rafael Perez CristiáTherapeutic Innovation & Regulatory Science 55 (1) 163 (2021)
https://doi.org/10.1007/s43441-020-00202-7
Quel prix pour les médicaments orphelins ?
Catherine Le GalèsLes Tribunes de la santé N° 62 (4) 61 (2020)
https://doi.org/10.3917/seve1.062.0061